+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Temodar"

TEMODAR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

TEMODAR Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Temodar - API Insight, 2022 - Product Thumbnail Image

Temodar - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Temodar- Drug Insight, 2019 - Product Thumbnail Image

Temodar- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Temodar is a brand name for temozolomide, a chemotherapy drug used to treat certain types of skin cancer. It is a type of alkylating agent, which works by interfering with the growth of cancer cells. Temodar is used to treat melanoma, a type of skin cancer that can spread to other parts of the body. It is also used to treat basal cell carcinoma, a type of skin cancer that is usually localized to the skin. Temodar is typically administered orally, and is available in both capsule and oral suspension forms. Temodar is marketed by Merck & Co., Inc., and is available in the United States, Canada, and Europe. It is also available in some other countries, including Australia, New Zealand, and South Africa. Other companies that market temozolomide include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more